Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongyi Huang

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Epilepsia|June 30, 2026
Anterior cingulate cortex neuron subtypes differentially regulate seizuresZiqian Yan, Ting Tang, Kaishan Wang, et al.
Advanced Healthcare Materials|January 12, 2026
Linker Manipulation with Beta<sup>3</sup>-Amino Acids Potentiates the Efficacy and Safety of PSMA RadiopharmaceuticalsXin Gao, Jie Ma, Siqi Zhang, et al.
Journal of Medicinal Chemistry|October 25, 2025
<sup>64</sup>Cu-Labeled Stapled Peptide-Based Radiopharmaceuticals Targeting MDM2/MDMX for Pan-p53 TumorsHao Tian, Quan Zuo, Siqi Zhang, et al.
Journal of Medicinal Chemistry|April 15, 2026
Leveraging Diverse Bi-Triazine Cross-linkers for Modulating Conformation and Biological Activity of Cyclic and Dimeric PeptidesQuan Zuo, Ximiao Yang, Junlong Lu, et al.
Journal of Medicinal Chemistry|January 27, 2026
Revitalizing PI3K Inhibitors for PET/CT Imaging and Radionuclide Therapy of Multiple CancersHongyi Huang, Shouguo Peng, Quan Zuo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 17, 2025
Carbon Monoxide Nanomodulator Reverses Ischemia-Reperfusion Injury in Stroke: A Novel Dual-Channel Therapy Mode of Co-driving Neuroprotection and NeurogenesisXuegang Niu, Bin Gao, Hongyi Huang, et al.
Pharmacological Research|February 16, 2026
First-in-Human Evaluation of Four Novel PSMA-Targeted PET Radiotracers with Non-canonical Amino Acid Linkage: A Comparative StudyDong Dai, Xin Gao, Siqi Zhang, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translationYuxuan Wu, Xingkai Wang, Xiaona Sun, et al.
Scientific Reports|January 18, 2025
Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancerLuyao Zhang, Shunfang Liu, Jingliang He, et al.
Nature Protocols|January 24, 2024
An end-to-end workflow for nondestructive 3D pathologyKevin W Bishop, Lindsey A Erion Barner, Qinghua Han, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Epilepsia|June 30, 2026
Anterior cingulate cortex neuron subtypes differentially regulate seizuresZiqian Yan, Ting Tang, Kaishan Wang, et al.
Advanced Healthcare Materials|January 12, 2026
Linker Manipulation with Beta<sup>3</sup>-Amino Acids Potentiates the Efficacy and Safety of PSMA RadiopharmaceuticalsXin Gao, Jie Ma, Siqi Zhang, et al.
Journal of Medicinal Chemistry|October 25, 2025
<sup>64</sup>Cu-Labeled Stapled Peptide-Based Radiopharmaceuticals Targeting MDM2/MDMX for Pan-p53 TumorsHao Tian, Quan Zuo, Siqi Zhang, et al.
Journal of Medicinal Chemistry|April 15, 2026
Leveraging Diverse Bi-Triazine Cross-linkers for Modulating Conformation and Biological Activity of Cyclic and Dimeric PeptidesQuan Zuo, Ximiao Yang, Junlong Lu, et al.
Journal of Medicinal Chemistry|January 27, 2026
Revitalizing PI3K Inhibitors for PET/CT Imaging and Radionuclide Therapy of Multiple CancersHongyi Huang, Shouguo Peng, Quan Zuo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 17, 2025
Carbon Monoxide Nanomodulator Reverses Ischemia-Reperfusion Injury in Stroke: A Novel Dual-Channel Therapy Mode of Co-driving Neuroprotection and NeurogenesisXuegang Niu, Bin Gao, Hongyi Huang, et al.
Pharmacological Research|February 16, 2026
First-in-Human Evaluation of Four Novel PSMA-Targeted PET Radiotracers with Non-canonical Amino Acid Linkage: A Comparative StudyDong Dai, Xin Gao, Siqi Zhang, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translationYuxuan Wu, Xingkai Wang, Xiaona Sun, et al.
Scientific Reports|January 18, 2025
Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancerLuyao Zhang, Shunfang Liu, Jingliang He, et al.
Nature Protocols|January 24, 2024
An end-to-end workflow for nondestructive 3D pathologyKevin W Bishop, Lindsey A Erion Barner, Qinghua Han, et al.
Pageof 4